ZOONOZIS - VECTOR-BORNE DISEASES / REVIEW PAPER
ANALYSIS OF THE METHODS FOR DIAGNOSING BORRELIOSIS − LYME DISEASE
1
Department of Histology and Embryology with Experimental Cytology Unit, Medical University of Lublin, Poland
Publication date: 2017-07-28
Health Prob Civil. 2017;11(2):80-86
KEYWORDS
ABSTRACT
Lyme borreliosis is a multi-organ disease transmitted by ticks, whose etiological factor is an
anaerobic bacterium Borrelia burgdorferi sensu lato. The incidence of this disease has risen
each year for more than 10 years now in all parts of the world where ticks are present. Due to
the multiplicity of the clinical symptoms, the disease is difficult to diagnose as it resembles
other illnesses. Further, its pathomechanism through which Borrelia burgdorferi spirochetes
attack joints, heart, nervous system and skin is not fully understood. This leads to many
problems, both diagnostic and therapeutic.
At present, there are two views on Lyme disease: one forwarded by the Polish Society of
Epidemiology and Physicians of Infectious Diseases and the other one recommended by the
International Lyme and Associated Diseases Society.
The following article presents clinical diagnostic procedures as well as additional laboratory,
serological, histological, microbiological and genetic analyzes. It is an attempt to provide
the most reliable diagnostic methods although it should be noted that all of them encounter
difficulties. Accordingly, the diagnosis of Lyme disease is far from perfect and requires
further research and standardization.
anaerobic bacterium Borrelia burgdorferi sensu lato. The incidence of this disease has risen
each year for more than 10 years now in all parts of the world where ticks are present. Due to
the multiplicity of the clinical symptoms, the disease is difficult to diagnose as it resembles
other illnesses. Further, its pathomechanism through which Borrelia burgdorferi spirochetes
attack joints, heart, nervous system and skin is not fully understood. This leads to many
problems, both diagnostic and therapeutic.
At present, there are two views on Lyme disease: one forwarded by the Polish Society of
Epidemiology and Physicians of Infectious Diseases and the other one recommended by the
International Lyme and Associated Diseases Society.
The following article presents clinical diagnostic procedures as well as additional laboratory,
serological, histological, microbiological and genetic analyzes. It is an attempt to provide
the most reliable diagnostic methods although it should be noted that all of them encounter
difficulties. Accordingly, the diagnosis of Lyme disease is far from perfect and requires
further research and standardization.
REFERENCES (82)
1.
Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny, Zakład Epidemiologii. Główny.
2.
Inspektorat Sanitarny Departament Zapobiegania oraz Zwalczania Zakażeń i Chorób Zakaźnych u Ludzi.
3.
Choroby Zakaźne i Zatrucia w Polsce w 2016 roku. Podstawowe tablice robocze – wstępne dane, stan w dniu.
5.
Ocias LF, Jensen BB, Knudtzen FC, Skarphedinsson S, Dessau RB. Clinical manifestations, diagnosis and.
7.
Zając V, Wójcik-Fatla A, Sawczyn A, Cisak E, Sroka J, Kloc A, et al. Prevalence of infections and co-infections.
8.
with 6 pathogens in Dermacentor reticulatus ticks collected in eastern Poland. Ann Agric Environ Med.
10.
Biesiada G, Czepiel J, Leśniak M, Garlicki A, Mach T. Analiza czynników epidemiologicznych, objawów.
11.
klinicznych i markerów serologicznych w przebiegu boreliozy. Przegl Epidemiol. 2010; 67: 181-183 (in.
13.
Kwak ML. Keys for the morphological identification of the Australian paralysis ticks (Acari: Ixodidae), with.
14.
scanning electron micrographs. Exp Appl Acarol. 2017 May 11. doi: 10.1007/s10493-017-0133-y. [Epub.
16.
Clow KM, Ogden NH, Lindsay LR, Michel P, Pearl DL, Jardine CM. The influence of abiotic and biotic factors.
17.
on the invasion of Ixodes scapularis in Ontario, Canada. Ticks Tick Borne Dis. 2017 Mar 21. pii: S1877-.
18.
959X(17)30029-8. doi: 10.1016/j.ttbdis.2017.03.003. [Epub ahead of print].
19.
Mukhacheva TA, Kovalev SY. Borreliaspirochetes in Russia: genospecies differentiation by real-time PCR.
21.
Pancewicz SA. Borelioza z Lyme – zasady rozpoznawania i leczenia. Pediatr Med. Rodz. 2014; 10: 163-173.
23.
Wang G, van Dam AP, Schwartz I, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic,.
24.
epidemiological, and clinical implications. Clin Microbiol Rev. 1999; 12: 633–653.
25.
Wilske B. Diagnosis of Lyme borreliosis in Europe. Vector Borne Zoonotic Dis. 2003; 3: 215–227.
26.
Kondrusik M. Biologia i morfologia krętka Borrelia burgdorferi. In: Hermanowska-Szpakowicz T., editor.
28.
Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012; 379: 461–473.
30.
Patel KP, Farjo PD, Juskowich JJ, Hama Amin A, Mills JD. Early-onset Lyme carditis with concurrent.
32.
Wormser GP, Sudhindra P, Lopez E, Patel L, Rezai S, Brumbaugh AD, et al. Fatigue in patients with erythema.
34.
Goddard J. Not All Erythema Migrans Lesions Are Lyme Disease. Am J Med. 2017; 130(2): 231–233.
35.
Maraspin V, Nahtigal Klevišar M, Ružić-Sabljić E, Lusa L, Strle F.Borrelial Lymphocytoma in Adult Patients.
37.
Jabłońska S, Chorzelski T. Choroby skóry. Warszawa: Wydawnictwo Lekarskie PZWL; 2008 (in Polish).
38.
Cianciara J, Jacek J. Choroby zakaźne i pasożytnicze. Lublin: CZELEJ; 2007 (in Polish).
39.
Błażejewicz-Zawadzińska M, Brochocka A, Lisińska J, Borowiecki MA. A retrospective analysis of 973.
40.
patients with Lyme borreliosis in Kuyavian-Pomeranian voivodship in 2000-2005. Przegl Epidemiol. 2012;.
42.
Lesire V, Machet L, Toledano C, de Muret A, Maillard H, Lorette G, et al. Atypical erythema multiforme.
43.
occurring at the early phase of Lyme disease? Acta Derm Venereol. 2000; 80(3): 222.
44.
Gaubitz M, Dressler F, Huppertz HI, Krause A. Kommission Pharmakotherapie der DGRh. Diagnosis and.
45.
treatment of Lyme arthritis. Recommendations of the Pharmacotherapy Commission of the Deutsche.
46.
Gesellschaft für Rheumatologie (German Society for Rheumatology) Z Rheumatol. 2014; 73(5): 469-74.
47.
Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis, Ann Intern Med. 1987; 107: 725-31.
48.
Skowronek-Bała B, Wesołowska E, Gergont A, Kaciński M. Neuroboreliosis with motoric disturbations in.
50.
Glatz M, Müllegger RR. Cutaneous manifestations of Lyme disease: Pitfalls in the serological diagnostic.
52.
Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment,.
53.
treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical.
54.
practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006; 43: 1089-1134.
55.
Leeflang MMG, Ang CW, Berkhout J, Bijlmer HA, Van Bortel W, Brandenburg AH, et al. The diagnostic.
56.
accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis. BMC.
58.
Schoen RT. Editorial commentary: better laboratory testing for Lyme disease: no more Western blot. Clin.
60.
Brunner M, Sigal LH. Use of Serum Immune Complexes in a New Test That Accurately Confirms Early Lyme.
61.
Disease and Active Infection with Borrelia burgdorferi J Clin Microbiol. 2001; 39(9): 3213–3221.
62.
von Baehr V, Doebis C, Volk HD, von Baehr R. The Lymphocyte Transformation Test for Borrelia Detects.
63.
Active Lyme Borreliosis and Verifies Effective Antibiotic Treatment. Open Neurol J. 2012; 6: 104–112.
64.
Puri BK, Segal DRM, Monro JA. Diagnostic use of the lymphocyte transformation test-memory lymphocyte.
65.
immunostimulation assay in confirming active Lyme borreliosis in clinically and serologically ambiguous.
67.
Jin Ch, Roen DR, Lehmann PV, Kellermann GH. An Enhanced ELISPOT Assay for Sensitive Detection of.
68.
Antigen-Specific T Cell Responses to Borrelia burgdorferi. Cells. 2013; 2(3): 607–620.
69.
Pomelova VG, Korenberg EI, Kuznetsova TI, Bychenkova TA, Bekman NI, Osin NS. C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis. PLoS One. 2015; 10(7): e0130048.
70.
Chmielewski T, Fiett J, Gniadkowski M, Tylewska-Wierzbanowska S. Improvement to laboratory recognition.
71.
of Lyme borreliosis with the combination of culture and PCR methods. Mol Diagn. 2003; 7(3/40): 155-162.
72.
Strube Ch, Montenegro VM, Epe Ch, Eckelt E, Schnieder T. Establishment of a minor groove binder-probe.
73.
based quantitative real time PCR to detect Borrelia burgdorferi sensu lato and differentiation of Borrelia.
75.
Douglas T, Tamburro D, Fredolini C, Espina B, Lepene BS, Ilag L, et al. The Use of Hydrogel Microparticles.
76.
to Sequester and Concentrate Bacterial Antigens in a Urine Test for Lyme Disease. Biomaterials. 2011 Feb;.
78.
Centers for Disease Control and Prevention (CDC) Recommendations for test performance and interpretation.
79.
from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly.
81.
Baker PJ, Wormser GP. The Clinical Relevance of Studies on Borrelia burgdorferi Persisters. Am J Med. 2017;.
Share
RELATED ARTICLE
| eISSN: | 2354-0265 |
| ISSN: | 2353-6942 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
